References
- Huben RP. Chemotherapy of prostatic cancer—A review. Prostate cancer, S Khoury, C Chatelain, G Murphy, L Denis. FIIS Publ., Paris 1989; 483–90
- Pilepich M V, AL Sarraf M, Rotman M, Ratkin G, Zinniger M, Oss D. Adjuvant chemotherapy with adriamycin, cytoxan and cis-platinum in high-grade carcinoma of the prostate treated with definitive radiotherapy (RTOG pilot 81–12). Am J Clin Oncol 1986; 9: 135–8
- de Vere White R, Babaian R K, Feldman M, Krane R, Olsson CA. Adjunctive therapy with interstitial irradiation for prostate cancer. Urology 1982; 19: 395–8
- de Vere White R, Babaian R K, Krikorian J, Krane R J, Olsson CA. Adjuvant chemotherapy for stage D1 adenocarcinoma of the prostate. Urology 1983; 21: 270–2
- Brausi M, Soloway MS. Progression and complications after external beam radiation therapy for carcinoma of prostate. Urology 1989; 34: 115–9
- Carter G E, Lieskovsky G, Skinner D G, Petrovich Z. Results of local and/or systemic adjuvant therapy in the management of pathological stage C or D1 prostate cancer following radical prostatectomy. J Urol 1989; 142: 1266–70
- Schmidt J D, Gibbons R, Murphy G, Bartolucci A. Investigators of the National Prostatic Cancer Project (NPCP). Adjuvant treatment of localized prostate cancer following radical surgery and definitive irradiation. Presented at Annual Meeting of the American Society of Clinical Oncologists. Georgia, Atlanta May, 1988; 17–19
- Schmidth J D, Gibbons R P, Bartolucci A, Murphy G P. Investigatorsof the National Prostatic Cancer Treatment Group. Prognosis in stage D1 prostate cancer relative to anatomic sites of nodal metastases. Cancer 1989; 8: 1743–6